It has long been recognised that one way to reduce the allergic symptoms of allergy sufferers is to desensitise their immune systems by exposing them to much higher doses of allergen than they are used to – taking care to monitor symptoms under medically controlled conditions as the allergen dose is slowly increased. This often relieves symptoms for several years but will eventually need to be re-done. This is effective for the treatment of hay fever (seasonal rhinitis) and a number of other allergies – there has even been experimentation with severe allergy.
Scientists are now attempting to discover why the treatment does not last longer than it does. With standard therapy requiring 3 years of exposure to the allergen it is costly and inconvenient. In this study they tried giving an antigen for only 2 years and found no benefit after 1 year of stopping treatment, whereas treatment for 3 years was effective for 6 years or more. Cost saving is not supported in this instance and treatment is best continued for the full 3 years.
Submitted by GAtherton on Mon, 2017-02-20 14:44
Share this post
Latest News posts
Clean Air and Lung Health
January 29, 2019
ERS Vision: Take the Active Option for your Health
January 29, 2019
Push-ups for Aspergillosis Research
January 29, 2019
What is Aspergillosis? – Fungal Infections & Symptoms
January 29, 2019
Aspergillosis & antibody testing
January 29, 2019
Patients Meeting – Rome 2010
January 29, 2019
Some health effects of mould exposure
January 29, 2019
Interview with CPA patient RW on long term antifungal treatments
January 29, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video